Philips expands interventional oncology portfolio with EmboGuide to see, reach and treat tumor lesions

Dokument -

Philips expands interventional oncology portfolio with EmboGuide to see, reach and treat tumor lesions

· New live 3D image guidance tool enhances tumor embolization procedures on Philips’ interventional X-ray systems. · Philips innovations detect more than twice as many tumor feeding arteries compared to standard DSA, while lesion detection is superior to standard DSA and now comparable to gold standard contrast-enhanced MRI [1,2].
  • Lisens: Bruk i media
    Innholdet kan lastes ned, bli brukt og delt i ulike medier av for eksempel journalister, bloggere, spaltister, kommentatorer etc., med den hensikt å formidle, fortelle og kommentere dine pressemeldinger, oppslag eller informasjon, forutsatt at innholdet er uendret og brukt i sin helhet. Opphaver skal navngis i den grad og på den måten god skikk tilsier (dette betyr f.eks. at fotografer nesten alltid skal navngis).
  • Filformat: .pdf
Last ned

Kontakter

Anne-Cathrine Tjørnehøj

Pressekontakt Press Contact for Lighting Philips Lighting Tel: +45 403 308 06

Anna Ekholm

Pressekontakt Sr Marketing Specialist Healthcare Nordic +46 708322109

Relatert innhold

Philips expands interventional oncology portfolio with EmboGuide to see, reach and treat tumor lesions

· New live 3D image guidance tool enhances tumor embolization procedures on Philips’ interventional X-ray systems. · Philips innovations detect more than twice as many tumor feeding arteries compared to standard DSA, while lesion detection is superior to standard DSA and now comparable to gold standard contrast-enhanced MRI [1,2].